A Phase 1 Study of Oprozomib to Assess Food Effect, Drug-Drug Interaction With Midazolam, and Safety and Tolerability in Patients With Advanced Malignancies

Clinical trial NCT02244112 · TERMINATED

Trial details

NCT number: NCT02244112
Sponsor: Amgen
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Non-Central Nervous System (CNS) Malignancies

Start date: 2014-08-01
Primary completion: 2015-05-15
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.